As of 2024-07-27, the Relative Valuation of Paratek Pharmaceuticals Inc (PRTK) is (17.29) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.23 USD, the upside of Paratek Pharmaceuticals Inc based on Relative Valuation is -875.4%.
The range of the Relative Valuation is (18.28) - (11.16) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.1x - 10.2x | 10.1x |
| Forward P/E multiples | 16.7x - 26.2x | 21.4x |
| Fair Price | (18.28) - (11.16) | (17.29) |
| Upside | -919.6% - -600.6% | -875.4% |
| Date | P/E |